Series A Common Stock Purchase Warrants (November 2025 PIPE)
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: NYSE
DilutionScan read 22 of NANOVIRICIDES, INC.'s SEC filings and found 11 warrant series, 2 convertibles, 2 ATM programs, 5 shelf registrations and 3 completed offerings on file for NNVC. The latest dilution event on file is a registration statement on Aug 31, 2026. Analysis updated Oct 26, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 64 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 31, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2024
Total capacity
Sold to date
Issued 2026
Total capacity
Sold to date
Issued 2023
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2025
Total capacity
Remaining
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z